Intelligent dosing platform system with prior authorization and pharmacy benefit manager integration

An intelligent dosing platform system for prior authorization and pharmacy benefit management integration with automated decision-making, comprising:

• a plurality of intelligent injection devices deployed across multiple healthcare settings, each intelligent injection device comprising a barrel having a first end and a second end configured to receive and store a pharmaceutical, a needle connected with the first end of the barrel and in fluid communication with the barrel, a piston positioned within the second end of the barrel, a microprocessor in electronic communication with a wireless module configured to transmit authorization request data and usage data, and a locking mechanism engaged with a stalk of the piston and configured to prevent medication administration pending authorization approval;
• a prior authorization module configured to receive medication release approval from one or more of pharmacies, distributing agents, or payor entities for one or more of medication regimens or singular medications, receive medication administration requests from the plurality of intelligent injection devices across healthcare facilities, analyze authorization requirements based on aggregated device data from the plurality of intelligent injection devices, individual payor policies, pharmacy benefit manager formularies, medical necessity criteria, seasonality factors affecting medication coverage, and timing considerations related to authorization request patterns, automatically evaluate step therapy requirements and formulary tier restrictions for prescribed medications, and generate authorization decisions based on real-time policy compliance analysis and collective device usage patterns;
• a multi-payor integration engine configured to maintain communication interfaces with multiple insurance payors and pharmacy benefit manager systems, synchronize policy updates from diverse reimbursement entities in real-time, translate authorization requirements across different payor policy formats and terminology, aggregate authorization data from multiple payer sources for unified decision-making, and coordinate medication release approvals from pharmacy and distributing entities;
• an aggregated data analytics module configured to analyze collective data from the plurality of intelligent injection devices to inform authorization decisions, identify usage patterns across patient populations that affect coverage determinations, evaluate medication efficacy and adherence trends from device data, assess seasonality patterns in medication requests and authorization requirements, analyze timing factors including request frequency and temporal patterns that influence authorization likelihood, and generate insights from device fleet data to optimize authorization processes;
• an automated decision module configured to approve or deny medication administration requests based on comprehensive policy evaluation and aggregated device analytics, apply clinical appropriateness criteria including one or more of diagnosis verification or treatment guideline compliance informed by device usage data, evaluate formulary alternatives when requested medications face authorization barriers, consider seasonality and timing factors in authorization determinations, and generate denial reasons with specific policy citations and appeal pathway information;
• a downstream action coordinator configured to prevent intelligent injection device shipment when prior authorization is denied, update electronic health record systems with authorization status and clinical documentation requirements, generate automated alerts to healthcare providers for authorization failures requiring intervention, trigger inventory management updates to release authorized medications for patient delivery, initiate supply chain processes including one or more of pharmacy fulfillment or medication distribution coordinated with authorization approvals, coordinate billing system updates for one or more of claims submission or reimbursement processing, and maintain authorization workflow documentation for audit and compliance purposes;
• a financial reconciliation engine configured to reconcile payment flows when prior authorization module stops distribution of medications, match approved medication quantities with actually shipped medications based on pharmacy fulfillment data and device tracking information, match approved medication quantities with actually administered medications based on device usage data transmitted from the plurality of intelligent injection devices, ensure one-to-one correspondence between authorization approvals and fulfillment activities according to contractual stipulations between payors and pharmacies, verify that pharmacies receive payment for all medications actually shipped or administered to patients, prevent payors from making payments for medications that were unapproved or for which authorization was denied, reconcile funds between payors and other responsible parties based on benefit design specifications, identify discrepancies between authorized quantities and shipped or administered quantities, generate financial reconciliation reports documenting payment matches and discrepancies, trigger payment adjustments when authorization changes occur after initial shipment or administration, and maintain audit trails of financial reconciliation activities for regulatory compliance and contractual verification;
• a fraud, waste, and abuse detection module configured to analyze medication request patterns across the plurality of intelligent injection devices for fraudulent activity indicators, identify suspicious authorization attempts including one or more of duplicate requests or inappropriate prescribing patterns, correlate device usage data with authorization requests to detect waste or abuse of medications, generate fraud risk scores based on pattern recognition algorithms and historical fraud data, alert compliance officers and payors when fraudulent patterns are detected, and utilize aggregated device data to identify systemic fraud patterns across multiple healthcare settings;
• a pharmacy benefit eligibility verification system configured to confirm patient coverage status with pharmacy benefit managers in real-time, verify medication coverage under patient-specific benefit plans considering seasonality and timing factors, determine patient cost-sharing obligations including one or more of copayments or deductibles, coordinate medication release approvals with pharmacy and distributing entities, and identify patient assistance program eligibility for high-cost medications;
• an appeals management module configured to track authorization denials requiring appeals or peer-to-peer review, manage documentation submission for authorization appeals processes including device usage data supporting medical necessity, monitor appeals timelines and generate reminders for time-sensitive response requirements, document appeals outcomes to inform future authorization decisions, and coordinate financial reconciliation adjustments when appeals result in retroactive authorizations;
• a policy analytics system configured to analyze authorization approval rates across different payors and pharmacy benefit managers, evaluate impact of seasonality and timing factors on authorization patterns, identify authorization bottlenecks and policy barriers affecting patient access to medications, correlate device usage data with authorization outcomes to optimize policy application, provide recommendations for prior authorization process optimization, and generate reports for healthcare administrators regarding authorization efficiency, denial patterns, and financial reconciliation accuracy;
• and
• wherein the system is configured to optimize medication access through streamlined prior authorization workflows informed by aggregated device data, prevent fraudulent medication requests through pattern recognition across device fleet and real-time monitoring, ensure payor compliance through automated policy application considering seasonality and timing factors, facilitate accurate financial reconciliation between authorization approvals and actual medication shipment or administration, protect pharmacy financial interests by ensuring payment for all dispensed medications, protect payor financial interests by preventing payment for unauthorized or unadministered medications, facilitate patient care continuity through rapid authorization decisions and coordinated downstream actions, and maintain regulatory compliance through comprehensive audit trails, fraud prevention measures, and financial reconciliation documentation.

A method for automated prior authorization and pharmacy benefit management in an intelligent medication administration platform, comprising:

• receiving, by a prior authorization module, medication administration request data from an intelligent injection device, wherein the intelligent injection device comprises a barrel in fluid communication with a needle, a piston positioned within the barrel, and a microprocessor in electronic communication with a wireless module;
• receiving, by the prior authorization module, medication release approval for one or more of a medication regimen or a singular medication from one or more of a pharmacy, a distributing agent entity, or a payor entity;
• aggregating, by a data analytics module, usage data from a plurality of intelligent injection devices to inform authorization decision-making processes;
• analyzing, by an artificial intelligence module, prior authorization requirements by evaluating one or more of individual payor policies, pharmacy benefit manager formulary restrictions, step therapy requirements, medical necessity criteria, aggregated device usage patterns, seasonality factors affecting medication coverage, or timing considerations related to authorization request patterns;
• determining, by an automated decision engine, authorization approval or denial based on real-time policy evaluation including one or more of coverage verification, formulary tier placement, clinical appropriateness criteria informed by collective device data, seasonality analysis, or timing pattern assessment;
• integrating, by a multi-stakeholder coordination module, policy updates from multiple payors, pharmacy benefit managers, and healthcare entities to maintain current authorization requirements across diverse reimbursement landscapes;
• triggering, by an automated action coordinator, downstream processes based on authorization decisions including one or more of preventing device shipment when prior authorization is denied, updating electronic health records with authorization status and denial reasons, generating healthcare provider alerts for authorization failures requiring appeal or alternative treatments, updating inventory management systems to release authorized medications for distribution, initiating supply chain processes to fulfill approved medication requests coordinated with pharmacy and distributing entities, or coordinating billing system updates for claims processing and reimbursement tracking;
• reconciling, by a financial reconciliation module, payment flows when the prior authorization module stops distribution of medications, wherein reconciling comprises matching approved medication quantities with actually shipped medications based on pharmacy fulfillment tracking, matching approved medication quantities with actually administered medications based on device usage data from the plurality of intelligent injection devices, ensuring one-to-one correspondence between authorization approvals and fulfillment activities according to contractual stipulations, verifying that pharmacies receive payment for all medications shipped or administered, preventing payors from making payments for unapproved medications or medications for which authorization was denied, and reconciling funds between payors and responsible parties based on benefit design specifications;
• detecting, by a fraud, waste, and abuse monitoring module, suspicious patterns in one or more of device usage, medication requests, or authorization attempts across the plurality of intelligent injection devices that may indicate fraudulent activity or inappropriate utilization;
• generating, by a real-time notification system, authorization status updates to one or more of patients, healthcare providers, pharmacies, or payors through multiple communication channels;
• generating, by the financial reconciliation module, reconciliation reports documenting matches and discrepancies between authorized medications and shipped or administered medications for pharmacy payment verification and payor payment validation;
• maintaining, by an audit trail module, comprehensive documentation of one or more of authorization decisions, policy applications, stakeholder communications, financial reconciliation activities, or payment matching processes for regulatory compliance and appeals processing;
• and
• optimizing, by a machine learning system, authorization processing efficiency by learning from one or more of historical authorization patterns, approval rates, appeals outcomes, aggregated device usage data, seasonality trends, or timing patterns to predict authorization likelihood and streamline approval workflows.